Bank Pictet & Cie (Europe)’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,318
| Closed | -$158K | – | 197 |
|
|
2024
Q4 | $158K | Buy |
21,318
+1,950
| +10% | +$14.4K | ﹤0.01% | 163 |
|
|
2024
Q3 | $182K | Sell |
19,368
-23,605
| -55% | -$222K | ﹤0.01% | 151 |
|
|
2024
Q2 | $345K | Sell |
42,973
-10,917
| -20% | -$87.6K | 0.01% | 130 |
|
|
2024
Q1 | $799K | Sell |
53,890
-9,073
| -14% | -$134K | 0.02% | 114 |
|
|
2023
Q4 | $512K | Buy |
62,963
+19,239
| +44% | +$156K | 0.02% | 181 |
|
|
2023
Q3 | $199K | Buy |
43,724
+7,905
| +22% | +$36K | 0.01% | 251 |
|
|
2023
Q2 | $252K | Sell |
35,819
-2,146
| -6% | -$15.1K | 0.01% | 233 |
|
|
2023
Q1 | $232K | Buy |
37,965
+9,879
| +35% | +$60.4K | 0.01% | 166 |
|
|
2022
Q4 | $179K | Buy |
28,086
+410
| +1% | +$2.62K | 0.01% | 161 |
|
|
2022
Q3 | $265K | Hold |
27,676
| – | – | 0.01% | 149 |
|
|
2022
Q2 | $306K | Sell |
27,676
-206
| -0.7% | -$2.28K | 0.01% | 134 |
|
|
2022
Q1 | $464K | Buy |
27,882
+2,893
| +12% | +$48.1K | 0.02% | 128 |
|
|
2021
Q4 | $477K | Buy |
24,989
+2,927
| +13% | +$55.9K | 0.02% | 133 |
|
|
2021
Q3 | $544K | Sell |
22,062
-2,010
| -8% | -$49.6K | 0.02% | 128 |
|
|
2021
Q2 | $626K | Buy |
24,072
+17,575
| +271% | +$457K | 0.02% | 126 |
|
|
2021
Q1 | $206K | Buy |
+6,497
| New | +$206K | 0.01% | 172 |
|